跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,127 条关于
“BOLD-HTN”
全部
4,127
临床试验
3,206
药物
312
机构
52
资讯
557
去年
E-Star BioTech Initiates Phase 2 Trial of MANP for Resistant Hypertension Treatment
去年
Renal Denervation Shows Promise in Managing Hypertension Variability
去年
Bold Therapeutics Presents Breakthrough Data on BOLD-100's Neuroprotective Effects at AACR 2025
去年
Mineralys Therapeutics Completes Enrollment in Lorundrostat Phase 3 Hypertension Trial Ahead of Schedule
上个月
Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint
去年
Idorsia Launches IMPACT-HTN Initiative with Stanford and Duke to Transform Difficult-to-Control Hypertension Care
3个月前
Australia's Tumour-Agnostic Immunotherapy Approvals: A Bold Policy Experiment Requiring National Data Infrastructure
去年
Mineralys Therapeutics Completes Enrollment in Lorundrostat Hypertension Trials, Anticipates 2025 Data
9个月前
Mineralys Therapeutics' Lorundrostat Trial Recognized in JAMA's Inaugural "Research of the Year" for Treatment-Resistant Hypertension
2年前
UK Takes Bold Step to Ban Xylazine and 21 Other Substances in Major Drug Control Initiative
第 1 页,共 56 页
上一页
下一页